Dan Secor joined Gilde Healthcare in 2020 in the Cambridge office and focuses on the Healthtech sector. He was part of Gilde’s investment team in Eargo, where he served as a board observer.
Before joining Gilde, Dan worked as a consultant at Health Advances, assisting clients across all sectors of healthcare in commercial strategy and M&A due diligence. Project work included go-to-market strategy and launch planning, indication prioritization, competitive analysis, and forecasting.
Dan studied physics and economics at the University of Pennsylvania. Dan is a US citizen.
Dr. Paul Parren